Showing results (341-350 of 1,002) with videos related to
Sort By:
Pageof 101
Ejhaem|February 23, 2023
Eight-color multiparameter flow cytometry (EuroFlow-NGF) is as sensitive as next-generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myelomaRyota Urushihara, Naoki Takezako, Takeshi Yoroidaka, et al.Ejhaem|February 23, 2023
GSK3 inhibitor enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistanceAki Inase, Yimamu Maimaitili, Shiro Kimbara, et al.Ejhaem|February 23, 2023
Investigating and modeling positron emission tomography factors associated with large cell transformation from low-grade lymphomasJean-Pierre Obeid, Susan M Hiniker, Joseph Schroers-Martin, et al.Ejhaem|April 25, 2022
Children with sickle cell disease and severe COVID-19 presenting single nucleotide polymorphisms in innate immune response genes - A case reportNatália Lima Pessoa, Lilian Martins Oliveira Diniz, Adriana de Souza Andrade, et al.Ejhaem|July 18, 2022
Imagining the cell therapist: Future CAR T cell monitoring and intervention strategies to improve patient outcomesMichael D Jain, Jay Y SpiegelEjhaem|July 18, 2022
CAR-T-OPENIA: Chimeric antigen receptor T-cell therapy-associated cytopeniasAlankrita Taneja, Tania JainEjhaem|July 18, 2022
Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasmsMichael J Hochman, Bipin N Savani, Tania JainEjhaem|July 18, 2022
Bleeding is associated with intravenous immunoglobulin and therapeutic plasma exchange use in heparin-induced thrombocytopenia: A propensity matched analysisAlexandre Soares Ferreira Júnior, Stephen H Boyle, Maragatha Kuchibhatla, et al.Ejhaem|July 18, 2022
Gabapentin for acute pain in sickle cell disease: A randomized double-blinded placebo-controlled phase II clinical trialLatika Puri, Kerri Nottage, Jane S Hankins, et al.Pageof 101